A Healthcare scenario from the (not so far) future

Shortly after a person is born, her genotype is recorded at her physician’s office, and the information is transmitted to a secure database. Here, genotype means the presence or absence of specific variations in genes known to be relevant for assessing disease susceptibility and predicting responses to known drug types. Assisted by a decision support system, her physician may prescribe a personal immunization and screening schedule or recommend specific preventive measures. The genotyping information is complemented throughout her life by a screening program based on bio-molecular profiling. At any point, screening may lead to recommendations about life-style or nutrition, or to detection of early stages of a disease. Refined diagnosis and choice of personalized therapy follow, which take into account her genotype and patient history and details of her molecular health profile.

 

Chris Sander Genomic Medicine and the Future of Health Care, Science, 287, pp. 1977-1978

Translating omics − The Pharmacogenomics Dimension

Learn More About eMoDiA

Vision.

Shortly after a person is born, her genotype is recorded at her physician’s office, and the information is transmitted to a secure database.
More...

Aims.

eMoDiA targets its R&D efforts towards the design, development and deployment of an electronic Pharmacogenomics (PGx) Assistant Web-based platform. More...

Contact.

Department of Pharmacy, University of Patras, 265 00, Patras, Greece

Phone: (+30) 2610 962339
Fax: (+30) 2610 962339

This email address is being protected from spambots. You need JavaScript enabled to view it.